New York City, NY -- (SBWIRE) -- 01/14/2014 -- To receive alerts before the crowd, please take 7 seconds to sign up for our Premium SMS Alerts. Grab your cell phone and text the word "PICKS" to "555888”.
StockMarketIntel.com issues a special report on the following stocks: SPDR S&P 500 ETF Trust (NYSEARCA:SPY), Sirius XM Holdings Inc. (NASDAQ:SIRI), Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN), J.C. Penney Company, Inc. (NYSE:JCP)
SPDR S&P 500 ETF Trust (NYSEARCA:SPY) declined -1.35%, trading on 35.25 million shares, to end the trade at $181.66. The stock changed hands in a range of $181.34 to $184.17, bringing its market capitalization to about $171.61 billion. If we look at its trading history of the past 52 weeks, the share price suffered a low of $146.20 and was moved to the maximum level of $184.69. SPDR S&P 500 ETF Trust (the Trust) is an exchange traded fund. The Trust corresponds to the price and yield performance of the S&P 500 Index. The S&P 500 Index is composed of 500 selected stocks and spans over 24 separate industry groups. The Fund’s investment sectors include information technology, financials, energy, health care, consumer staples, industrials, consumer discretionary, materials, utilities and telecommunication services.
Has SPY Found The Bottom and Ready To Move Up? Find Out Here
Sirius XM Holdings Inc. (NASDAQ:SIRI) declined -0.81%, to complete the trading session at $3.67, with a total volume of 110.89 million shares. The stock, on average, trades on a volume of 75.51 million shares. It floated in a range of $3.65 to $3.76 during the last trading session, with a beta value of 1.46. Its market capitalization now moved to about $22.70 billion. In the past 52 weeks, the share price has not declined below $2.95 and above $4.18.
Has SIRI Found The Bottom And Ready To Gain Momentum? Find Out Here
Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN) recorded a gain of 40.35% and was in a range of $1.41-$1.85 before closing at $1.60. The stock completed the day with a total volume of 79.71 million shares, versus an average volume of 3.99 million shares. The share price hit its 52-week low of $0.28 and $1.85 was the best price. Rexahn Pharmaceuticals, Inc. (Rexahn) is a development-stage biopharmaceutical company. The Company focuses on the development of cures for cancer to patients worldwide. The Company’s pipeline features one drug candidate in Phase II clinical trials. The Company also has several other drug candidates in pre-clinical development.
What was the Moving Force behind RNN on Bullish Run? Read This Research Report
J.C. Penney Company, Inc. (NYSE:JCP) declined -8.45% yesterday, bringing its market capitalization around $2.05 billion. The share price, after opening at $7.33, made a high of $7.41 and hovered above $6.67 to end the day at $6.72. The total number of shares that changed hands during the session was 68.91 million shares, as compared to average trading volume of 30.72 million shares. J. C. Penney Company, Inc. is a holding company whose principal operating subsidiary is J. C. Penney Corporation, Inc. (JCP). The Company’s business consists of selling merchandise and services to consumers through its department stores and through its Internet Website at jcp.com.
Why Should Investors Buy JCP After the Recent Fall? Just Go Here and Find Out
To receive alerts before the crowd, please take 7 seconds to sign up for our Premium SMS Alerts. Grab your cell phone and text the word "PICKS" to "555888”.
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list.
Neither StockMarketIntel.com, nor its employees and affiliates are registered as investment advisors or broker/dealers in any jurisdiction whatsoever. Through use of this website viewing or using you agree to hold StockMarketIntel.com, its operators, owners, employees, and affiliates harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Readers should always do their own due diligence and consult a financial professional. StockMarketIntel.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and StockMarketIntel.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled company. Any opinions expressed on this website are statements of judgment as of the date of publication and are subject to change without further notice, and may not necessarily be reprinted in future publications or elsewhere.
Read Full disclaimer at: http://stockmarketintel.com/Disclaimer.htm
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)